Short Interest in CV Sciences, Inc. (OTCMKTS:CVSI) Decreases By 94.0%

CV Sciences, Inc. (OTCMKTS:CVSI) was the recipient of a significant decrease in short interest during the month of January. As of January 31st, there was short interest totalling 6,400 shares, a decrease of 94.0% from the January 15th total of 106,400 shares. Based on an average trading volume of 317,300 shares, the short-interest ratio is presently 0.0 days.

CV Sciences Stock Down 1.6 %

Shares of OTCMKTS:CVSI traded down $0.00 during midday trading on Wednesday, hitting $0.04. 348,179 shares of the stock traded hands, compared to its average volume of 221,746. CV Sciences has a one year low of $0.03 and a one year high of $0.10. The business’s 50 day moving average is $0.04 and its two-hundred day moving average is $0.04. The stock has a market capitalization of $7.85 million, a PE ratio of -4.25 and a beta of 0.69.

CV Sciences Company Profile

CV Sciences, Inc develops, manufactures, markets, and sells herbal supplements and hemp-based cannabidiol (CBD) in North America. It operates in two segments, Consumer Products and Specialty Pharmaceutical. The company offers its products under the PlusCBD, ProCBD, HappyLane, CVAcute, CVDefense, and PlusCBD Pet brands in the health care market sector, including nutraceutical, beauty care, specialty foods, and pet products through its websites, elect distributors, brick and mortar retailers, and select e-tailers.